These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 396544)

  • 1. A study of the caeruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups.
    Gibbs K; Walshe JM
    Q J Med; 1979 Jul; 48(191):447-63. PubMed ID: 396544
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease.
    Gollan JL; Stocks J; Dormandy TL; Sherlock S
    J Clin Pathol; 1977 Jan; 30(1):81-3. PubMed ID: 838874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
    Walshe JM;
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):115-21. PubMed ID: 12662398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of liver enzymes, serum ceruloplasmin and urine copper in parents of children with Wilson's disease.
    Haghighat M; Dehghani SM; Imanieh MH; Gholami S
    Saudi Med J; 2008 Jul; 29(7):1056-7. PubMed ID: 18626543
    [No Abstract]   [Full Text] [Related]  

  • 7. [Proceedings: Differentiation of homozygote and heterozygote, therapy and follow-up study in 4 families with Wilson's disease].
    Abendschein Th; Przuntek H; Wesch H; Gäng V
    MMW Munch Med Wochenschr; 1975 May; 117(20):842. PubMed ID: 805973
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
    Kanai M; Nomoto S; Tsukagoshi H; Shindo M
    Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
    [No Abstract]   [Full Text] [Related]  

  • 9. Wilson's disease: diagnostic difficulties in the patient with chronic hepatitis and hypoceruloplasminemia.
    Spechler SJ; Koff RS
    Gastroenterology; 1980 Apr; 78(4):803-6. PubMed ID: 7353765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The question of a false-structured ceruloplasmin in Wilson's disease].
    Kühn HJ; Mörtzschky I
    Z Med Lab Diagn; 1984; 25(5):250-6. PubMed ID: 6485485
    [No Abstract]   [Full Text] [Related]  

  • 11. Routine screen for Wilson's disease?
    Scheinberg IH
    Ann Neurol; 1990 Apr; 27(4):450-1. PubMed ID: 2353802
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunocytochemical identification of caeruloplasmin in hepatocytes of patients with Wilson's disease.
    Graul RS; Epstein O; Sherlock S; Scheuer PJ
    Liver; 1982 Sep; 2(3):207-11. PubMed ID: 6184593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathobiochemistry of Wilson's disease].
    Biesold D; Lössner J; Bachmann H; Zotter J
    Z Med Lab Diagn; 1982 Oct; 23(5):278-84. PubMed ID: 7180077
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of calculated non-caeruloplasmin-bound copper in Wilson's disease.
    Duncan A; Yacoubian C; Beetham R; Catchpole A; Bullock D
    Ann Clin Biochem; 2017 Nov; 54(6):649-654. PubMed ID: 27742851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction of molecular forms of ceruloplasmin with specific membrane receptors from healthy persons and patients with hepatolenticular degeneration].
    Puchkova LV; Verbina IA; Gaĭtskoki VS; Neĭfakh SA
    Biokhimiia; 1991 Dec; 56(12):2261-9. PubMed ID: 1666959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular forms of ceruloplasmin in hepatolenticular degeneration and their interaction with human erythrocyte ceruloplasmin receptor.
    Puchkova LV; Verbina IA; Denezhkina VV; Vakharlovskii VG; Voitsekhovskii BL; Gaitskhoki VS; Neifakh SA
    Biomed Sci; 1990; 1(5):460-6. PubMed ID: 1966785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kinetics of radioactive copper in Wilson's disease].
    Willvonseder R; Goldstein NP; Tauxe WN
    Wien Z Inn Med; 1973; 54(5):226-33. PubMed ID: 4790777
    [No Abstract]   [Full Text] [Related]  

  • 19. [Wilson's disease. Summary of studies carried out in a family group with Wilson's disease. Significance of amino-acid balance in homo and heterozygotes for the detection of liver damage].
    Degli Esposti A; Antener I; Ambrosioni G; Bonfiglioli G
    Minerva Pediatr; 1976 Nov; 28(34):2063-86. PubMed ID: 1012227
    [No Abstract]   [Full Text] [Related]  

  • 20. [Wilson's disease: an unusual case].
    Llagostera Campillo F; Garrido Botella A; Abreu García L; Barrios Peinado C; Gonzalo Molina MA; Pabón Jaén M; Chantar Barrios C; Fernández Corugedo A; Escartín Marín P
    Rev Esp Enferm Apar Dig; 1983 Jul; 64(1):43-8. PubMed ID: 6612070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.